These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31898228)

  • 1. The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer.
    Liu X; Zurlo G; Zhang Q
    Adv Exp Med Biol; 2020; 1217():173-186. PubMed ID: 31898228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.
    Hansen WJ; Ohh M; Moslehi J; Kondo K; Kaelin WG; Welch WJ
    Mol Cell Biol; 2002 Mar; 22(6):1947-60. PubMed ID: 11865071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer.
    Huang KT; Dobrovic A; Fox SB
    Breast Cancer Res Treat; 2010 Dec; 124(3):853-6. PubMed ID: 20680678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
    Iwai K; Yamanaka K; Kamura T; Minato N; Conaway RC; Conaway JW; Klausner RD; Pause A
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12436-41. PubMed ID: 10535940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Elongin C and Skp1 sequences that determine Cullin selection.
    Yan Q; Kamura T; Cai Y; Jin J; Ivan M; Mushegian A; Conaway RC; Conaway JW
    J Biol Chem; 2004 Oct; 279(41):43019-26. PubMed ID: 15280393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
    Sufan RI; Jewett MA; Ohh M
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F1-6. PubMed ID: 15180922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein.
    Pause A; Peterson B; Schaffar G; Stearman R; Klausner RD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9533-8. PubMed ID: 10449727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.
    Kamura T; Burian D; Yan Q; Schmidt SL; Lane WS; Querido E; Branton PE; Shilatifard A; Conaway RC; Conaway JW
    J Biol Chem; 2001 Aug; 276(32):29748-53. PubMed ID: 11384984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta.
    Iturrioz X; Durgan J; Calleja V; Larijani B; Okuda H; Whelan R; Parker PJ
    Biochem J; 2006 Jul; 397(1):109-20. PubMed ID: 16669786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
    Maynard MA; Ohh M
    Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1.
    Lai Y; Song M; Hakala K; Weintraub ST; Shiio Y
    Arch Biochem Biophys; 2012 Feb; 518(2):103-10. PubMed ID: 22234250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic dissection of the von Hippel-Lindau (VHL) interactome.
    Lai Y; Song M; Hakala K; Weintraub ST; Shiio Y
    J Proteome Res; 2011 Nov; 10(11):5175-82. PubMed ID: 21942715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
    Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases.
    Mahrour N; Redwine WB; Florens L; Swanson SK; Martin-Brown S; Bradford WD; Staehling-Hampton K; Washburn MP; Conaway RC; Conaway JW
    J Biol Chem; 2008 Mar; 283(12):8005-13. PubMed ID: 18187417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex.
    Cardote TAF; Gadd MS; Ciulli A
    Structure; 2017 Jun; 25(6):901-911.e3. PubMed ID: 28591624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex.
    Nguyen HC; Yang H; Fribourgh JL; Wolfe LS; Xiong Y
    Structure; 2015 Mar; 23(3):441-449. PubMed ID: 25661653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.
    Yun J; Kim YI; Tomida A; Choi CH
    Biochem Biophys Res Commun; 2009 Nov; 389(1):5-9. PubMed ID: 19695223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions.
    Cai W; Yang H
    Cell Div; 2016; 11():7. PubMed ID: 27222660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor.
    Nyhan MJ; O'Sullivan GC; McKenna SL
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):472-8. PubMed ID: 18481984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.